Atypical course of COVID-19 in patient with Bruton agammaglobulinemia

20Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

Abstract

We present atypical course of the novel coronavirus disease (COVID-19) in 34-year man with Bruton agammaglobulinemia. The patient was successfully treated by a combination of available drugs, including convalescent plasma and interleukin-6 (IL-6) inhibitor.

Cite

CITATION STYLE

APA

Milošević, I., Jovanović, J., & Stevanović, O. (2020). Atypical course of COVID-19 in patient with Bruton agammaglobulinemia. Journal of Infection in Developing Countries, 14(11), 1248–1251. https://doi.org/10.3855/jidc.13840

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free